Science and Technology

A new prescription flu drug, Xofluza, created with research done 40 years ago by Robert Krug, professor emeritus of molecular biosciences, was recently approved by the Food and Drug Administration and will be available across the U.S. in the coming weeks. 

Almost a third of all graduating medical students in the U.S. have participated in a global health volunteer experience, and while most of the students reported that they were positive, many evaluations of the impact of these programs have been negative, according to a 2014 Medical Student Research Journal study.

Have no fear, lasers are here: UT scientists work on improving anxiety-oriented therapy through non-invasive lasers.

While research application of CRISPR technology mostly includes scientist’s hand-directed editing of genomes, UT researchers are studying how the natural mechanism of CRISPR works. Two groups of UT molecular scientists have recently published papers in journals Molecular Cell and Cell, respectively, that delve deeper into how CRISPR works in the natural world for defense against certain bacterial infections.